Univar Solutions and Novozymes® Announce Expanded Distribution Agreement in Latin America
Univar Solutions (NYSE: UNVR) has expanded its partnership with Novozymes, a leader in biological solutions, to enhance distribution in Latin America. The agreement focuses on distributing enzymes for dairy and protein sectors in Brazil, Colombia, Ecuador, Peru, and Bolivia, while in Mexico and Central America, the entire food and beverage enzyme portfolio will be distributed. This strategic move is expected to leverage growth opportunities and strengthen Univar's offerings in the food ingredients sector.
- Expansion of distribution agreement with Novozymes into Latin America.
- Focus on high-demand sectors: dairy and protein in Brazil; protein and brewing in Colombia, Ecuador, Peru, and Bolivia.
- Potential for significant growth in food ingredients market.
- None.
DOWNERS GROVE, Ill., April 20, 2021 /PRNewswire/ -- Univar Solutions Inc. (NYSE: UNVR) ("Univar Solutions" or "the Company"), a global chemical and ingredient distributor and provider of value-added services, today announced an agreement to expand its existing global relationship with Novozymes, a world leader in biological solutions, to include Latin America. Under terms of the new agreement, Univar Solutions will distribute enzymes for the dairy and protein ingredient sectors in Brazil and the protein ingredient and brewing sectors in Colombia, Ecuador, Peru and Bolivia. Meanwhile, in Mexico and Central America, Univar Solutions will distribute Novozymes' entire food and beverage enzyme portfolio.
"Our strategic collaboration with Novozymes demonstrates our commitment to providing customers with the finest raw materials and solutions from world-class producers and this affords Univar Solutions a significant opportunity to expand our food ingredients business into Latin America," said Kevin Hack, vice president of global Food Ingredients at Univar Solutions. "We see significant growth potential for Novozymes' portfolio as we continue to expand our partnership and strengthen our offering to customers across Latin America."
Novozymes is a global leader in the production and development for the food and beverage industries and impacting the sustainable growth of these markets. Novozymes and Univar Solutions started their business relationship in 2004. Since then, the companies' partnership has expanded across geographies and serving several food ingredients market segments to now include Latin America.
"We are proud to be one of the leading global food ingredient distributors, but the value we bring to partners like Novozymes goes far beyond distribution," commented Jorge Buckup, president, Latin America, for Univar Solutions. "Our value-added services offering is fueled by our team of food scientists in test kitchens and Solution Centers around the world. By providing customers and partners with insight regarding top market trends, access to best-in-class ingredients and unmatched services and solutions, we create value and advance go-to-market efforts."
Across Latin America, Univar Solutions helps customers create streamlined, highly efficient production cycles and offers deep experience across a vast range of industries. Through our partnerships with suppliers like Novozymes, we're well-positioned to help customers anticipate, navigate and leverage growth opportunities.
"As we continue to bring innovative enzyme products to market, we recognize the importance of a successful and expansive distribution partnership," said Viviane Pereira de Souza, director of Consumer Biosolutions-AS at Novozymes South America.
"We are happy to expand our relationship with Univar Solutions in Latin America and to be able to build the same model of success that we have already achieved around the world, providing solutions and innovation in biotechnology for food and beverage industries," added Ángel Cortés, sales manager at Nozozymes Mexico, Central America & Caribbean.
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, Novozymes improves industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, its bio-innovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com.
About Univar Solutions
Univar Solutions (NYSE: UNVR) is a leading global specialty chemical and ingredient distributor representing a premier portfolio from the world's leading producers. With the industry's largest private transportation fleet and North American sales force, unparalleled logistics know-how, deep market and regulatory knowledge, world-class formulation and recipe development, and leading digital tools the company is well-positioned to offer tailored solutions and value-added services to a wide range of markets, industries, and applications. Univar Solutions is committed to helping customers and suppliers innovate and grow together. Learn more at UnivarSolutions.com.
Forward-Looking Statements
This press release includes certain statements relating to future events and our intentions, beliefs, expectations, and predictions for the future, which are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company's control. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the expectations and assumptions. A detailed discussion of these factors and uncertainties is contained in the Company's filings with the Securities and Exchange Commission. Potential factors that could affect such forward-looking statements include, among others: the ultimate geographic spread of the COVID-19 pandemic; the duration and severity of the COVID-19 pandemic; actions that may be taken by governmental authorities to address or otherwise mitigate the impact of the COVID-19 pandemic; the potential negative impacts of COVID-19 on the global economy and our customers and suppliers; the overall impact of the COVID-19 pandemic on our business, results of operations and financial condition; other fluctuations in general economic conditions, particularly in industrial production and the demands of our customers; significant changes in the business strategies of producers or in the operations of our customers; increased competitive pressures, including as a result of competitor consolidation; significant changes in the pricing, demand and availability of chemicals; our levels of indebtedness, the restrictions imposed by our debt instruments, and our ability to obtain additional financing when needed; the broad spectrum of laws and regulations that we are subject to, including extensive environmental, health and safety laws and regulations; an inability to integrate the business and systems of companies we acquire, including of Nexeo Solutions, Inc., or to realize the anticipated benefits of such acquisitions; potential business disruptions and security breaches, including cybersecurity incidents; an inability to generate sufficient working capital; increases in transportation and fuel costs and changes in our relationship with third party providers; accidents, safety failures, environmental damage, product quality and liability issues and recalls; major or systemic delivery failures involving our distribution network or the products we carry; operational risks for which we may not be adequately insured; ongoing litigation and other legal and regulatory risks; challenges associated with international operations; exposure to interest rate and currency fluctuations; potential impairment of goodwill; liabilities associated with acquisitions, ventures and strategic investments; negative developments affecting our pension plans and multi-employer pensions; labor disruptions associated with the unionized portion of our workforce; and the other factors described in the Company's filings with the Securities and Exchange Commission. We caution you that the forward-looking information presented in this press release is not a guarantee of future events or results, and that actual events or results may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "plan," "seek, "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise, except as required by law.
###
View original content to download multimedia:http://www.prnewswire.com/news-releases/univar-solutions-and-novozymes-announce-expanded-distribution-agreement-in-latin-america-301273139.html
SOURCE Univar Solutions Inc.
FAQ
What is the significance of Univar Solutions' agreement with Novozymes?
Which countries are involved in Univar Solutions' new distribution agreement?
How does the partnership with Novozymes impact Univar Solutions' business?
What sectors will benefit from Univar's expanded distribution in Latin America?
When was the expanded agreement between Univar Solutions and Novozymes announced?
